|
Invited Speakers:
|
|
Alba Guijarro Belmar Head of Vector Development, Sania Therapeutics
Avencia Sanchez-Mejias CEO and Co-Founder, Integra Therapeutics
Claire Kerridge Head of Gene Therapy, MHRA
Nathalie Cartier-Lacave Vice President Neurobiology, AskBio
Nuno Barata Global Medical Director, Novartis Gene Therapies
Victor Ferrero Associate Director, Global Product Strategy, BioMarin
Alberto del Rio Espinola Director, GentiBio Inc
Amin Hajitou Professor, Reader in Neuroinflammation, Imperial College London
Breech Conrad Odu Process Development Scientist, Merck Life Sciences
Charlotte Smerdon Senior Director, Clinical Operations, Purespring Therapeutics
Claudio Mussolino Group Leader, Medical Center - University of Freiburg
Dina Du Senior Scientist, AstraZeneca
Elina Hessels Associate Director Analytical Platforms, uniQure
Ellina Allais Regulatory Affairs Senior Director, Cellectis S.A.
Eugenio Macchiarulo Director MSAT, Barinthus Bio
Giandomenico Turchiano Associate Director, Gene Editing Safety, AstraZeneca
Isabelle Richard Director of Research, Genethon
James Norton Director Analytical Development, MeiraGTx
Jane Kinghorn Director, Translational Research Office, University College London
Johnson Varghese VP, Head of Analytical Research and Development, Beam Therapeutics
Julia Berretta CEO, Genespire
Khalid Saeed Senior scientist, AstraZeneca
Koval Smith Senior Manager DS/DP MSAT, Orchard Therapeutics
Laurence Guianvarc'h Head of Upstream & Downstream Process Development, Nantes University
Lilian Hook Director Cell, Apheresis and Gene Therapies, NHS Blood and Transplant
Michel Degueldre Lead GT Biophysical Sciences, UCB
Nathalie Uzcategui Senior Scientist, Hansa BioPharma
Nina Kotsopoulou , AAVantgarde Bio
Otmane Boussif Chief Technology Officer, Anjarium Biosciences
Pamela Whalley Associate Director CMC, Complementtx
Patricia Lareo Value Chain Capability Lead Gene Therapy, Roche
Paul Carter Senior Director MSAT, Quell Therapeutics
Peter Pechan Head of Vector Biology, UCB
Rodolphe Clerval CEO, Coave Tx
Senior Representative , AviadoBio
Simon Eaglestone Director, Program Management, Bloomsburygtx
Vahap Aydogan QA Expert Cell and Gene Therapy, Novartis
Victor Dillard VP, Strategy & Operations, Resolution Therapeutics
Vinciane De Cupere Technical Lead Gene Therapy, UCB
Yu-Tsan (Richard) Liu Sr. Scientist, UCB Pharma
|
|
